AIM
VRNA

Alerce Investment Management’s Verona Pharma VRNA Stock Holding History

Alerce Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4.09M Sell
88,000
-117,880
-57% -$4.43M 7.19% 3
2024
Q3 		$5.92M Sell
205,880
-7,120
-3% -$175K 9.5% 3
2024
Q2 		$3.08M Buy
+213,000
New +$3.11M 6.04% 4

Other funds holding VRNA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alerce Investment Management's VRNA Position: Q4 2024 in Review

Alerce Investment Management reduced its Verona Pharma (VRNA) stake by 57% in Q4 2024, selling an estimated $4.43M and leaving 88,000 shares worth $4.09M. The position accounts for 7.19% of the portfolio, ranked #3.

Alerce Investment Management first reported a position in VRNA in Q2 2024 and has held it in 3 quarters since. The position peaked at $5.92M in Q3 2024. 191 funds tracked by Wall St. Rank hold VRNA as of Q4 2024.

  • Alerce Investment Management held 88,000 shares of Verona Pharma worth $4.09M as of Q4 2024.
  • Alerce Investment Management sold 117,880 Verona Pharma shares in Q4 2024, an estimated $4.43M.
  • Verona Pharma made up 7.19% of Alerce Investment Management's portfolio in Q4 2024, its #3 holding.
  • Alerce Investment Management first reported a position in Verona Pharma in Q2 2024 and has held it in 3 quarters since.
  • Alerce Investment Management's Verona Pharma position peaked at $5.92M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2024.

Based on Alerce Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.